Publication: CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization
Open/View Files
Date
2005
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Proceedings of the National Academy of Sciences
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Malley, R., K. Trzcinski, A. Srivastava, C. M. Thompson, P. W. Anderson, and M. Lipsitch. 2005. “CD4+ T Cells Mediate Antibody-Independent Acquired Immunity to Pneumococcal Colonization.” Proceedings of the National Academy of Sciences 102 (13) (March 21): 4848–4853. doi:10.1073/pnas.0501254102.
Research Data
Abstract
Acquired immunity to Streptococcus pneumoniae (pneumococcus) has long been assumed to depend on the presence of anticapsular antibodies. We found, however, that colonization with live pneumococci of serotypes 6B, 7F, or 14 protected mice against recolonization by any of the serotypes and that protection from acquisition of a heterologous or homologous strain did not depend on anticapsular antibody. Further, intranasal immunization by live pneumococcal colonization or by a killed, nonencapsulated whole-cell vaccine protected antibody-deficient mice against colonization, suggesting independence of antibodies to any pneumococcal antigens. Protection by intranasal immunization with whole-cell vaccine was completely abrogated in T cell-deficient mice, and in mice that were congenitally deficient in CD4+ T cells or depleted of these cells at the time of challenge. In contrast, mice congenitally deficient in, or depleted of, CD8+ T cells were fully protected. Protection in this model was observed beyond 2 months after immunization, arguing against innate or nonspecific immune mechanisms. Thus, we find that immunity to pneumococcal colonization can be induced in the absence of antibody, independent of the capsular type, and this protection requires the presence of CD4+ T cells at the time of challenge.
Description
Other Available Sources
Keywords
streptococcus pneumoniae, cell-mediated immunity, vaccine
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service